Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease
      Biotech

      Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease

      November 13, 2023
      Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
      Biotech

      Oxolife Appoints International Fertility Experts to its Scientific Advisory Board

      November 13, 2023
      Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
      Biotech

      Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery

      November 13, 2023
      Integrum’s OPRA™ Implant System gets FDA approval for clinical study on below-knee amputations
      Biotech

      Integrum’s OPRA™ Implant System gets FDA approval for clinical study on below-knee amputations

      October 30, 2023
      Sobi publishes Q3 2023 report: Strong revenue and solid performance
      Biotech

      Sobi publishes Q3 2023 report: Strong revenue and solid performance

      October 30, 2023
      Reminder: Invitation: Sobi’s Q3 2023 report
      Biotech

      Reminder: Invitation: Sobi’s Q3 2023 report

      October 27, 2023
      Global Oligonucleotide Synthesis Markets Research Report 2023-2027: RNA Based Vaccines, Genomic Blizzard, & Antisense Revival at the Forefront of Growth and Developments
      Biotech

      Global Oligonucleotide Synthesis Markets Research Report 2023-2027: RNA Based Vaccines, Genomic Blizzard, & Antisense Revival at the Forefront of Growth and Developments

      October 27, 2023
      Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
      Biotech

      Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy

      October 27, 2023
      Visgenx Announces Issuance of a U.S. Patent Claiming Compositions of Candidate ELOVL2 Gene Therapy
      Biotech

      Visgenx Announces Issuance of a U.S. Patent Claiming Compositions of Candidate ELOVL2 Gene Therapy

      October 25, 2023
      First patient treated in the second dose group in Annexin’s RVO study
      Biotech

      First patient treated in the second dose group in Annexin’s RVO study

      October 25, 2023
      « 1 … 89 90 91 92 93 … 139 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026